Related Experiment Video
Updated: Jul 1, 2025

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model
Published on: June 11, 2020
COVID-19 vaccines-associated Takotsubo cardiomyopathy: A narrative review
Shakiba Hassanzadeh1, Addi Suleiman2, Joaquim J Correia3
1Department of Pathology, East Carolina University, Greenville, North Carolina, USA.
Insights
Takotsubo cardiomyopathy (TTC) is a rare cardiac issue that has been reported following COVID-19 vaccination. While 16 cases are noted, a direct causal link requires further investigation, and vaccine benefits outweigh risks.
Area of Science:
- Cardiology
- Immunology
- Public Health
Background:
- Takotsubo cardiomyopathy (TTC) is a serious, temporary heart condition often affecting postmenopausal women after stress.
- The COVID-19 pandemic led to widespread vaccination, with various cardiac events reported post-immunization.
- A small number of TTC cases have been associated with COVID-19 vaccines.
Purpose of the Study:
- To review the existing literature on Takotsubo cardiomyopathy.
- To summarize reported cases of TTC following COVID-19 vaccination.
- To discuss the potential association between COVID-19 vaccines and TTC incidence.
Main Methods:
- Literature review of Takotsubo cardiomyopathy.
- Analysis of reported cases of TTC post-COVID-19 vaccination.
- Discussion of causality and risk-benefit analysis.
Main Results:
- Sixteen cases of COVID-19 vaccination-associated TTC have been reported.
- TTC is characterized by acute, reversible cardiac dysfunction.
- No direct cause-and-effect relationship between COVID-19 vaccines and TTC is established.
Conclusions:
- Further research is needed to explore the potential link between COVID-19 vaccines and TTC.
- The benefits of COVID-19 vaccination significantly outweigh the potential risks of adverse events like TTC.
- Continued monitoring of cardiac events post-vaccination is important.
Abstract:
Takotsubo cardiomyopathy (TTC) is a severe, acute, reversible, and self-limited cardiac dysfunction. It usually affects postmenopausal women and is mostly triggered by physical or emotional stressors. Following the COVID-19 pandemic, millions of doses of different types of COVID-19 vaccines are being administered globally. There have been reports of different cardiac complications after receiving COVID-19 vaccines. To our knowledge, there have been 16 reported cases of COVID-19 vaccination-associated TTC. In this study, we first provide a brief overview of TTC and then an overview of selected reported TTC cases following COVID-19 vaccinations. It is crucial to highlight that the occurrence of TTC after vaccination does not establish a direct cause-and-effect relationship between immunization and TTC. Further investigations are necessary to examine any potential association between COVID-19 vaccines and the incidence of TTC. Additionally, the benefits of receiving COVID-19 vaccines significantly outweigh the potential risks of developing adverse events.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Pathophysiology of Heart Failure
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...

